Self-organizing maps for identification of new inhibitors of P-glycoprotein.

Self-organizing maps were trained to separate high- and low-active propafenone-type inhibitors of P-glycoprotein. The trained maps were subsequently used to identify highly active compounds in a virtual screen of the SPECS compound library.

[1]  J. Gasteiger,et al.  ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .

[2]  J. Schellens,et al.  Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  S. Hirono,et al.  Simple Method of Calculating Octanol/Water Partition Coefficient. , 1992 .

[4]  C. Avendaño,et al.  Inhibitors of multidrug resistance to antitumor agents (MDR). , 2002, Current medicinal chemistry.

[5]  M. Gottesman,et al.  Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.

[6]  J. F. Wang,et al.  Prediction of P-Glycoprotein Substrates by a Support Vector Machine Approach , 2004, J. Chem. Inf. Model..

[7]  J. Gasteiger,et al.  Calculation of the Charge Distribution in Conjugated Systems by a Quantification of the Resonance Concept , 1985 .

[8]  J. Schellens,et al.  Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs. , 2006, Trends in pharmacological sciences.

[9]  T. Kohonen.  Self-Organized Formation of Correct Feature Maps , 1982 .

[10]  I. Pajeva,et al.  Molecular modeling of phenothiazines and related drugs as multidrug resistance modifiers: a comparative molecular field analysis study. , 1998, Journal of medicinal chemistry.

[11]  M. Gottesman,et al.  Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.

[12]  Stephan Kopp,et al.  Identification of ligand-binding regions of P-glycoprotein by activated-pharmacophore photoaffinity labeling and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. , 2002, Molecular pharmacology.

[13]  M. G. Hutchings,et al.  Quantification of effective polarisability. Applications to studies of X-ray photoelectron spectroscopy and alkylamine protonation , 1984 .

[14]  Jens Sadowski,et al.  The Use of Self-organizing Neural Networks in Drug Design , 2002 .

[15]  S. Ekins,et al.  Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates. , 2002, Molecular pharmacology.

[16]  G. Ecker,et al.  Inhibitors of ABC-type drug efflux pumps: an overview of the current patent situation , 2004 .

[17]  J Polanski,et al.  Self-organizing neural networks for screening and development of novel artificial sweetener candidates. , 2000, Combinatorial chemistry & high throughput screening.

[18]  M. Delaforge,et al.  Characterization of two pharmacophores on the multidrug transporter P-glycoprotein. , 2002, Molecular pharmacology.

[19]  Johann Gasteiger,et al.  Empirical Methods for the Calculation of Physicochemical Data of Organic Compounds , 1988 .

[20]  Stephan Kopp,et al.  Similarity based SAR (SIBAR) as tool for early ADME profiling , 2002, J. Comput. Aided Mol. Des..

[21]  Ling Yang,et al.  Classification of Substrates and Inhibitors of P-Glycoprotein Using Unsupervised Machine Learning Approach , 2005, J. Chem. Inf. Model..

[22]  I. Pajeva,et al.  Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis). , 2002, Journal of medicinal chemistry.

[23]  H. Lage.  ABC-transporters: implications on drug resistance from microorganisms to human cancers. , 2003, International journal of antimicrobial agents.

[24]  Johann Gasteiger,et al.  Rapid empirical calculation of the first (n or π) ionization potential of organic molecules , 1993, J. Comput. Chem..

[25]  I. Pajeva,et al.  A Comparative Molecular Field Analysis of Propafenone‐type Modulators of Cancer Multidrug Resistance , 1998 .

[26]  B. Hirst,et al.  The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.